Kidney cancer patients may get a break from treatment with targeted therapy

NCT ID NCT06770855

First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 25 times

Summary

This study tests whether giving focused radiation or surgery to all remaining cancer spots can allow kidney cancer patients to stop their regular treatment for at least a year. It involves 23 adults with metastatic clear cell kidney cancer who have already had stable or improved disease after at least 6 months of immunotherapy. The goal is to see if this approach can delay the need for more cancer therapy.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RENAL CELL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Abramson Cancer Center at University of Pennsylvania

    Philadelphia, Pennsylvania, 19104, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.